查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1490017

微生物组定序服务市场：按服务类型、按应用、按最终用户、按地区

Microbiome Sequencing Service Market, By Service Type, By Application, By End User, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3个工作天内

价格
简介目录

微生物组定序服务的全球市场规模预计到 2024 年为 19.7 亿美元，预计到 2031 年将达到 41.3 亿美元，2024 年至 2031 年的复合年增长率为 11.1%。

报告范围 报告详情
基准年 2023年 2024年市场规模 19.7亿美元
实际资料 2019年至2023年 预测期 从2024年到2031年
预测 2024-2031 年复合年增长率： 11.10% 2031年价值预测 41.3亿美元
图：2024 年按地区分類的微生物组定序服务市场占有率(%)
微生物组定序服务市场-IMG1

微生物组定序使用高通量定序技术来研究人体内部和与人体相关的微生物群落。人类微生物组是指体内存在的所有微生物的基因组。次世代定序技术的进步使得微生物群落的分析达到了前所未有的规模和解析度。微生物组定序服务透过标靶基因定序或全元基因组鸟枪定序提供各种微生物群落的基因组分析。这彻底改变了我们对微生物组与各种人类疾病、病理和药物反应之间关係的理解。研究我们身体内部和表面存在的复杂微生物生态系统可以为人类健康提供有价值的见解，并开启新的诊断、预后和治疗方法的可能性。

市场动态：

微生物组定序服务的全球市场受到各种疾病研究和药物开发活动中越来越多地采用微生物组分析的推动。微生物组研究显示肠道微生物与多种疾病之间存在联繫，包括肥胖、糖尿病、癌症以及神经和免疫疾病。这正在推动製药和生物技术公司对基于微生物组的治疗开发的投资。然而，由于大规模全宏基因组鸟枪法定序服务的成本较高，市场潜力仍受到限制。持续研究和开发负担得起的定序技术代表了市场扩张的重大机会。扩大微生物组分析在个人化营养和益生菌产品开发的应用也提供了良好的前景。微生物组分析公司和最终用户之间的合​​作越来越有助于开拓新的应用领域。

本研究的主要特点

  • 这份研究报告对全球微生物组定序服务市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它还强调了各个细分市场的潜在收益成长机会，并说明了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球微生物组定序服务市场的主要企业。
  • 主要企业包括 Microbiome Insights Inc.、Baseclear BV、Clinical Microbiomics A/S.、Merieux NutriSciences Corporation、MR DNA、Zymo Research Corporation、Metabiomics Corp.、uBiome, Inc.、Microbiome Therapeutics Innovation Group、Locus Biosciences, Inc. OpenBiome、Microbiome Therapeutics Innovation Group、Locus Biosciences, Inc. OpenBiome, Inc.上海瑞亿生物科技有限公司、BioSpherex LLC 和Diversigen。
  • 该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 微生物组定序服务的全球市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球微生物组定序服务市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章 市场动态、法规与趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 市场趋势
  • 主要进展
  • 监管场景
  • 收购和合作场景
  • 资金筹措和投资
  • PEST分析
  • 波特的分析

第四章全球微生物组定序服务市场－冠状病毒（COVID-19）大流行的影响

  • 整体影响
  • 政府倡议
  • COVID-19 对市场的影响

第五章全球微生物组定序服务市场，依服务类型，2019-2031

  • 6S rRNA 基因分析
  • 全基因组鸟枪法定定序
  • 标靶基因序列测定序
  • 单细胞定序
  • 其他的

第六章 全球微生物组定序服务市场（依应用），2019-2031

  • 肠道微生物群分析
  • 尿液微生物群分析
  • 其他的

第 7 章 全球微生物定序服务市场，依最终使用者划分，2019-2031 年

  • 学术研究所
  • 製药和生物技术公司
  • 诊断实验室
  • 其他的

第八章全球微生物组定序服务市场（按地区），2019-2031

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第9章 竞争格局

  • 公司简介
    • Microbiome Insights Inc.
    • Baseclear BV
    • Clinical Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH &Co. KG
    • BioSpherex LLC
    • Diversigen

第10章分析师建议

  • Wheel of Fortune
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
简介目录
Product Code: CMI6980

Global microbiome sequencing service market is estimated to be valued at USD 1.97 Bn in 2024 and is expected to reach USD 4.13 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 11.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 1.97 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 11.10% 2031 Value Projection: US$ 4.13 Bn
Figure. Microbiome Sequencing Service Market Share (%), By Region 2024
Microbiome Sequencing Service Market - IMG1

Microbiome sequencing involves using high-throughput sequencing technologies to study the microbial communities within and associated with the human body. The human microbiome refers to the genomes of all microorganisms that reside on or within bodies. Advances in next-generation sequencing technologies have enabled the analysis of microbial communities at an unprecedented scale and resolution. Microbiome sequencing services provide genomic analysis of various microbial communities through targeted gene sequencing or whole metagenomic shotgun sequencing. This has transformed our understanding of the connections between the microbiome and various diseases, conditions, and drug responses in humans. By studying the complex microbial ecosystems in and on our bodies, we can gain valuable insights into human health and open up possibilities for novel diagnostics, prognostics, and therapeutics.

Market Dynamics:

The global microbiome sequencing service market is driven by the rising adoption of microbiome analysis in various disease research and drug development activities. Microbiome research has shown links between gut microbes and various diseases like obesity, diabetes, cancer, and neurological and immune disorders. This is encouraging more investments by pharmaceutical and biotech firms into microbiome-based therapy development. However, the market potential is still restrained by the high costs associated with large-scale whole metagenomic shotgun sequencing services. Ongoing R&D into affordable sequencing techniques presents a major opportunity for market expansion. Growing application of microbiome profiling for developing personalized nutrition and probiotic-based products also present lucrative prospects. Partnerships between microbiome analysis firms and end-users are increasingly helping to tap new application segments.

Key Features of the Study:

  • This report provides an in-depth analysis of the global microbiome sequencing service market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global microbiome sequencing service market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this includes Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Merieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global microbiome sequencing service market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global microbiome sequencing service market.

Detailed Segmentation-

  • By Service Type:
    • 6S rRNA gene profiling
    • Whole genome shotgun sequencing
    • Targeted gene sequencing
    • Single-cell sequencing
    • Others
  • By Application:
    • Gut microbiome analysis
    • Urinary microbiome analysis
    • Others
  • By End User:
    • Academic and research institutes
    • Pharmaceutical and Biotechnology companies
    • Diagnostic laboratories
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Microbiome Insights Inc.
    • Baseclear B.V.
    • Clinical-Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH & Co. KG
    • BioSpherex LLC
    • Diversigen

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Service Type
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Microbiome Sequencing Service Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Microbiome Sequencing Service Market, By Service Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • 6S rRNA gene profiling
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Whole genome shotgun sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Targeted gene sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Single-cell sequencing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Microbiome Sequencing Service Market, By Application, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Gut microbiome analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Urinary microbiome analysis
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Microbiome Sequencing Service Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Academic and research institutes
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmaceutical and Biotechnology companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Diagnostic laboratories
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Microbiome Sequencing Service Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
      • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
      • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
      • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
      • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Microbiome Insights Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Baseclear B.V.
    • Clinical Microbiomics A/S
    • Merieux NutriSciences Corporation
    • MR DNA
    • Zymo Research Corporation
    • Metabiomics Corp.
    • uBiome, Inc.
    • Microbiome Therapeutics Innovation Group
    • Locus Biosciences, Inc.
    • OpenBiome
    • Shanghai Ruiyi Biotechnology Co., Ltd.
    • Resphera Biosciences, LLC
    • Molzym GmbH & Co. KG
    • BioSpherex LLC
    • Diversigen

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact